[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100547032":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":15,"centralContacts":19,"locations":28,"responsibleParty":46,"collaborators":10,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":50,"sex":56,"minAge":57,"maxAge":10,"enrollmentInfo":58,"targetDuration":10,"studyType":61,"phases":10,"briefSummary":62,"conditions":63,"keywords":10,"overallStatus":31,"whyStopped":10,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},{"fullName":5,"class":6},"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"retrospective cohort",null,"GEP- and Pulm- NET patients referred to the U.O.C. of Medical Oncology of the FPG - IRCCS since 01\u002F01\u002F2010 up to the date of approval of the study.",{"label":13,"type":10,"description":14,"interventionNames":10},"prospective cohort","GEP- and Pulm- NET patients referred to the U.O.C. of Medical Oncology of the FPG - IRCCS starting from the date of approval of the study for the following 36 months.",[16],{"name":17,"affiliation":5,"role":18},"Giovanni Schinzari","PRINCIPAL_INVESTIGATOR",[20,25],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Maria Grazia Maratta, MD","CONTACT","+39 0630156318","mariagrazia.maratta@guest.policlinicogemelli.it",{"name":26,"role":22,"phone":23,"phoneExt":10,"email":27},"Giovanni Schinzari, MD","giovanni.schinzari@policlinicogemelli.it",[29],{"facility":30,"status":31,"city":32,"state":10,"zip":33,"country":34,"countryCode":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"Fondazione Policlinico Universitario Agostino Gemelli - IRCCS","RECRUITING","Rome","00168","Italy","IT",{"type":37,"coordinates":38},"Point",[39,40],12.51133,41.89193,{"lat":40,"lon":39},[43,45],{"name":44,"role":22,"phone":10,"phoneExt":10,"email":24},"Maria Grazia Maratta",{"name":17,"role":22,"phone":10,"phoneExt":10,"email":27},{"type":47,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100547032","observational-study-on-gep-and-pulm-net-treated-at-fpg-100547032",false,"NCT06402695","Observational Study on GEP-and Pulm-NET Treated at FPG","Observational Study on Clinical, Laboratory, Anatomopathological and Molecular Characteristics and Their Prognostic and Predictive Value in Patients With Neuroendocrine Tumors of the Gastroenteropancreatic Tract and Pulmonary Treated at Fondazione Policlinico Agostino Gemelli (FPG)-IRCCS","ETNA-FPG","Inclusion Criteria:\n\n* histological diagnosis of gastroenteropancreatic or pulmonary NET\n* age ≥ 18 years;\n* radiological evidence of resectable\u002Flocally advanced\u002Fmetastatic disease;\n* signing of informed consent;\n* at least one visit following the first oncological visit.\n\nExclusion Criteria:\n\n* absence of clinical data that allow adequate definition of survival (primary endpoint of the study);\n* absence of histological diagnosis;\n* failure to sign the informed consent.","ALL","18 Years",{"count":59,"type":60},650,"ESTIMATED","OBSERVATIONAL","Observational ambispective monocentric study on the clinical, laboratory, pathological and molecular characteristics of patients suffering from gastroenteropancreatic tract and pulmonary neuroendocrine tumors and their prognostic and predictive value.",[64,65,66],"Neuroendocrine Tumors","Gep Net","Pulmonary Neuroendocrine Neoplasm","2024-05-03",{"date":69,"type":70},"2024-05-07","ACTUAL",{"date":72,"type":70},"2023-09-15",{"date":74,"type":60},"2026-07",{"name":5,"class":6},1]